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ABSTRACT  23 
Harmful consequences of cigarette smoke (CS) exposure during lung development can already 24 
manifest in infancy. In particular, early life exposure to nicotine, the main component of CS, was 25 
shown to affect lung development in animal models. We aimed to characterize the effect of 26 
nicotine on alveoli formation. We analyzed the kinetics of normal alveolar development during 27 
the alveolarization phase and then looked at the effect of nicotine in a mouse model of 28 
gestational and early life exposure. Immunohistochemical staining revealed that the wave of cell 29 
proliferation (i.e. vascular endothelial cells, alveolar epithelial cells (AEC) type II and 30 
mesenchymal cell) occurs at pnd8 in control and nicotine-exposed lungs. However, FACS 31 
analysis of individual epithelial alveolar cells revealed nicotine-induced transient increase of 32 
AEC type I proliferation and decrease of vascular endothelial cell proliferation at pnd8. 33 
Furthermore, nicotine increased the percentage of endothelial cells at pnd2. Transcriptomic data 34 
also showed significant changes in nicotine samples compared to the controls on cell cycle 35 
associated genes at pnd2, but not anymore at pnd16. Accordingly, the expression of survivin, 36 
involved in cell cycle regulation, also follows a different kinetics in nicotine lung extracts. These 37 
changes resulted in an increased lung size detected by stereology at pnd16, but no longer in adult 38 
age, suggesting that nicotine can act on the pace of lung maturation. Taken together, our results 39 
indicate that early life nicotine exposure could be harmful to alveolar development independently 40 
from other toxicants contained in CS.  41 
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INTRODUCTION  42 
During fetal development, lungs undergo several orchestrated steps to ensure adequate 43 
gas exchange. The successive embryonic, pseudoglandular, canalicular, saccular and alveolar 44 
phases are required to achieve functionality of the various parts of the lung, such as the 45 
conducting airways or respiratory units formed by alveoli (21, 53). Both genetic and 46 
environmental factors can influence lung development (18). The consequences of harmful events 47 
can manifest at birth, but also later in life. Exposure to cigarette smoke (CS) during early life has 48 
been widely associated with wheezing in childhood, and later in life with the development of 49 
chronic metabolic or cardiovascular diseases, such as diabetes or hypertension (5, 18), or chronic 50 
obstructive pulmonary disease (COPD) (10, 46, 47). Nicotine, one of the main components of 51 
CS, can freely cross the placenta and may harm the developing fetus (17). Nicotine exposure 52 
during pregnancy and lactation has been studied in rats and monkeys where it reduces gas 53 
exchange surface (39, 55). Furthermore, increased airway length and no change in the alveolar 54 
intercepts in mice exposed to nicotine were detected (58, 60). Finally, accelerated development 55 
of the bronchiolar tree was described in lambs (51). Most of the effects described worsened when 56 
pups were exposed to nicotine during the prenatal and postnatal period (10). In humans, there is 57 
no evidence that nicotine replacement therapy (NRT) induces major congenital abnormalities (8) 58 
and very few information is available on e-cigarette use during pregnancy (59). Since the effect 59 
of nicotine on alveolar development and in particular on the dynamics of cell death and 60 
proliferation has been poorly studied, we aim to better characterize a) the dynamics of different 61 
cell types during lung alveolarization, and b) the effect of in utero and lactation exposure to 62 
nicotine on the development of alveoli. Mice are born at the end of the saccular phase of lung 63 
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development, and therefore the process of alveolarization occurs after birth and is easier to study 64 
than in other animal species.  65 
To address our questions we exposed mice to nicotine during gestation and lactation to 66 
mimic pre- and postnatal exposure, and assessed lungs at post-natal day (pnd) 2 (end of saccular 67 
phase), 8 (early alveolar phase) and 16 (middle alveolar phase). Our results indicate dynamic 68 
processes of proliferation, with a peak detected at pnd8 and caused by three cell types: vascular 69 
endothelial cells, mature AEC type II and mesenchymal cells. Nicotine had no effect on 70 
proliferation dynamics when measured in the whole lung. Instead, we observed an effect on 71 
individual cell proliferation levels of endothelial cells and AEC type I cells that was 72 
accompanied by extensive genetic changes detected at the beginning of alveolar phase. Nicotine 73 
also increased lung and parenchyma volume and septal surface area at pnd16. The study of the 74 
cell cycle strongly suggest an acceleration in lung maturation. Majority of nicotine-induced 75 
changes were lost by pnd16, indicating that these effects are transient, except for the bigger lung 76 
volume detected at pnd16, that was no longer present in adult age. 77 
  78 
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LIST OF ABBREVIATIONS 79 
AEC     alveolar epithelial cell  80 
AQP5    Aquaporin 5  81 
COPD    chronic obstructive pulmonary disease 82 
CS    cigarette smoke  83 
Csf3    Granulocyte colony stimulating factor 3 84 
Dlx5    distal-less homebox 5 85 
Dmp1    cyclin D binding myb-like protein  86 
ECM     extracellular matrix 87 
FACS     Fluorescence-activated cell sorting 88 
Fgf23    Fibroblast growth factor 23 89 
Hox    Homebox gene 90 
HRP    Horseradish peroxidase 91 
Igf1     Insulin like growth factor 1 92 
Il    interleukin 93 
Irg1    Immune-responsive gene 1 94 
Ltbp4    Latent Transforming Growth Factor Beta Binding Protein 4 95 
MHCII    major histocompatibility complex class II  96 
MLI    mean linear intercept 97 
Nrp1    Neuropilin 1 98 
Orm    Orosomucoid 99 
PBS     phosphate buffered saline  100 
PCNA    proliferating cell nuclear antigen 101 
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Pdgf-a    Platelet Derived Growth Factor Subunit A 102 
PDPN    Podoplanin  103 
Pnd    post-natal day 104 
RML    right middle lobe 105 
RT    room temperature 106 
Serpina   Serpin Peptidase Inhibitor Clade A gene 107 
SPC     surfactant protein C  108 
TUNEL terminal deoxynucleotidyltransferase–mediated dUTP nick end 109 
labeling   110 
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MATERIALS AND METHODS 111 
Animals 112 
The animal procedures were performed in accordance with the Institutional Ethics Committee on 113 
Animal Care (Geneva, Switzerland) and the Cantonal Veterinary Office (authorization number 114 
GE/32/15 and GE/62/14). C57BL/6J mice (Mus Musculus) obtained from the animal facility of 115 
University of Geneva were kept under specific-pathogen-free conditions. Housing conditions 116 
were 12 hours day and 12 hours night. Mice had access to food and drinking water ad libitum. 117 
Nicotine (200 mg L-1) was started immediately after mating and administered to the females in 118 
drinking water supplemented with 2% saccharin for the whole period of gestation and lactation 119 
(nicotine group). Exposure to nicotine was determined by measurements of cotinine 120 
(measurements were done according to manufacturer protocol of ELISA kit, #501.301, 121 
Immunalysis, USA), the main metabolic product of nicotine, in the serum of the mothers and 122 
pups upon sacrifice at pnd 2-16. The values obtained for the mothers were 130 ± 88 ng/ml (n=8) 123 
and for the pups 70.6 ± 31 ng/ml (n=40), corresponding to values of medium to heavy smoker 124 
(36). There was no statistical difference in cotinine values measured at different pnd. As a 125 
control, we used drinking water with 2% saccharin (control group). Pups were sacrificed at pnd2, 126 
8 and 16 with Esconarkon (150 mg/kg, Streuli Pharma SA, Uznach) and lungs subjected to 127 
subsequent analysis. The litter size varied from 2-11 pups, and we did not normalize for it in our 128 
experiments. The sex of the pups was determined by testing for the expression of sycp3-like y-129 
linked and X-linked lymphocyte-regulated complex genes via PCR (29). Furthermore, female 130 
and male pups were analyzed together as one group as our preliminary experiments and literature 131 
suggests no effect of sex on lung development (40). Pups were not weaned at different pnd 132 
analyzed as they are normally weaned at pnd21. 133 
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Lung Instillation procedure was performed as described previously (34). Briefly, the 134 
airspace of the lung was filled with solution of 4% paraformaldehyde in phosphate buffered 135 
saline (10 mM sodium phosphate, containing 127 mM sodium chloride, pH 7.4) at a constant 136 
pressure of 20 cm water column. At this pressure, the lung reaches roughly its total lung capacity 137 
(49).  138 
 139 
Stereological analysis 140 
Lung volume was determined by applying the water displacement method (52). Five µm thick 141 
paraffin sections of the embedded right middle lobe (RML) lobes were cut along the longitudinal 142 
axis. Equally distributed sections obtained at 7 to 9 positions (depending on lung size) were dried 143 
overnight at 37˚C and stained with hematoxylin and eosin (26). Eighty to 100 images per RML 144 
(i.e. per animal) were acquired using a Leica DM RB light microscope (Glattbrugg, Switzerland) 145 
equipped with a motorized Maerzheuser XY stage (Wetzlar, Germany). N PLAN 20x/0.40 PH 1 146 
(Leica P/N 506024) objective was used. Images were taken with the ColorView IIIu 5 147 
MegaPixel CCD Color Camera (Olympus, Münster, Germany) provided by microscopy imaging 148 
center core facility at the University of Bern. Finally, 40 images per animal were selected using a 149 
systematic random sampling scheme (4).  150 
All the measurements were performed on lung RML. The volume of the RML, volume of the 151 
lung parenchyma and septa, septal surface area density and absolute septal surface area were 152 
estimated/calculated as described previously in (34).  153 
Gene expression  154 
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Offspring lungs were collected at pnd2 and 16, snap frozen in liquid nitrogen and stored at -155 
80˚C. RNA was isolated and purified using Macherey-Nagel purification kit (Germany). Six and 156 
five offspring lungs were used for pnd2 and 16 in control group and five and three offspring 157 
lungs were used for pnd2 and 16 in the nicotine group. cDNA libraries were constructed by the 158 
Genomic platform of the University of Geneva using the Illumina TruSeq RNA Sample 159 
Preparation Kit (CA, USA) according to the manufacturer's protocol. Libraries were sequenced 160 
using single-end (50nt-long) on Illumina HiSeq2500. FastQ reads were mapped to the 161 
ENSEMBL reference genome (GRCm38.80) using STAR version 2.4.0j (9) with standard 162 
settings, except that any reads mapping to more than one location in the genome (ambiguous 163 
reads) were discarded (m = 1). A unique gene model was used to quantify reads per gene. 164 
Briefly, the model considers all annotated exons of all annotated protein coding isoforms of a 165 
gene to create a unique gene where the genomic region of all exons are considered coming from 166 
the same RNA molecule and merged together. All reads overlapping the exons of each unique 167 
gene model were reported using feature Counts version 1.4.6-p1 (42). Gene expressions were 168 
reported as raw counts and in parallel normalized in RPKM in order to filter out genes with low 169 
expression value (1 RPKM) before calling for differentially expressed genes. Library size 170 
normalizations and differential gene expression calculations were performed using the package 171 
edgeR (48) designed for the R software (43). Only genes having a significant fold-change 172 
(Benjamini-Hochberg corrected p-value < 0.05) were considered for the rest of the RNAseq 173 
analysis. MDS plot was obtained with the package edgeR designed for R. Distances on the 174 
Multidimensional scaling plot represent the expression differences between samples (based on 175 
fold changes between samples). Data analysis was performed using MetaCore software 176 
(https://portal.genego.com/). Complete results of RNAseq analysis are deposited in Gene 177 
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Expression Omnibus (GEO) repository under the following link 178 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE102239. 179 
 180 
Immunohistochemistry staining 181 
Paraffin-embedded or cryosections of mouse lungs, collected at pnd2, 8 and 16, were stained 182 
according to the cell signaling technology standard protocol (https://www.cellsignal.com/). 183 
Briefly, paraffin-embedded samples were deparaffinized using xylene and 95-100% ethanol and 184 
subsequently hydrated in H2O. We applied the following antigen retrieval methods for single 185 
epitope staining: heat-induced epitope retrieval for 10 min in 0.01 mol/L citrate buffer (pH 6.0) 186 
for prosurfactant protein C (SPC) antigen and pressure-induced epitope retrieval (20 Bar) in 0.01 187 
mol/L citrate buffer (pH 6.0) for Ki67. Endogenous peroxidases were blocked with DAKO 188 
peroxidase block solution. Both primary and secondary antibodies were diluted with DAKO 189 
antibody diluent. We applied the primary antibodies for 1 hour at room temperature (RT). 190 
Finally, labelled polymer-HRP anti-rabbit or anti-mouse (Envision + system, DAKO, USA) was 191 
used for 30 min at RT and the signal was visualized with  diaminobenzidine (DAB, Envision + 192 
system) or 3-amino-9-ethylcarbazole (AEC) (Dako SA, Geneva, Switzerland). Sections were 193 
counterstained with Hematoxylin (BioGnost, Zagreb). Quantification of positive cells was 194 
performed with Definiens software (Germany) provided by bioimaging core facility at the 195 
University of Geneva or ImageJ software (U.S. National Institutes of Health). Images were taken 196 
with Axio scan.Z1 (Carl Zeiss, Germany). Quantification of positive cells was performed with 197 
Definiens software (Germany) provided by bioimaging core facility at the University of Geneva 198 
or ImageJ software.  199 
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Cryosections were fixed for 15 minutes (min) at RT in 4% paraformaldehyde (PFA), and 200 
subsequently washed 3 times for 5 min in PBS. The samples were further incubated in the 201 
blocking solutions (5% normal goat serum + 0.3% triton X-100 in PBS) for 1 hour at RT, and 202 
then exposed to primary antibodies (PDPN and CD31) diluted in the blocking solution for 1 hour 203 
at RT. Sections were than washed with PBS (3x5 min) and exposed to fluorochrome coupled 204 
secondary antibodies again for 1 hour at RT. The samples were then again washed with PBS and 205 
the nuclei were stained with DAPI (5 min at RT) and slides were mounted with FluorSaveTM 206 
reagent (Millipore). Images were acquired with Zeiss LSM800 confocal microscope with 207 
Apochromat objective 63x/N.A. 1.4 oil immersion and further processed by Imaris 208 
(https://imaris.oxinst.com/) and Huygens (HuygensSoftware) software. For all the information 209 
about the primary and secondary antibodies see the section “antibodies and reagents” in the 210 
supplemental material.  211 
Measure of cell death 212 
For paraffin sections of fixed lung, terminal deoxynucleotidyltransferase–mediated dUTP nick 213 
end labeling (TUNEL) was performed with an in situ apoptosis detection kit according to the 214 
protocol of the manufacturer (ApopTag®, Chemicon, Temecula, CA). Briefly, 5 μm thick 215 
paraffin sections were deparaffinized and then treated with proteinase K (ROCHE, 20 μg/ml 216 
30min 37°C) to unmask DNA. The mix containing TdT enzyme and Dig-labelled dNTP in a 217 
reaction buffer is added to the sections and allowed to react for 1h at 37°C with the free DNA 218 
resulting from strand breaks or fragmentation. dNTP tail is revealed using a horse radish 219 
peroxidase (HRP)-coupled anti-DIG antibody and AEC substrate. Sections were counterstained 220 
with Hematoxylin (BioGnost, Zagreb). As reported in Immunohistochemistry staining section, 221 
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Images were taken with Axio scan.Z1 and quantification of positive cells was performed with 222 
Definiens software. 223 
Western blot analysis 224 
Cells were lysed with the following buffer: TRIS 50 mM, NaCl 250 mM, Triton X-100 1%, 225 
Sodium Deoxycholate 0.5%, SDS 0.1%, pH 8.0. Total protein extract was quantified by means 226 
of a bicinchoninic acid protein assay reaction kit (Pierce, Rockford, IL, USA) and 40 μg were 227 
separated on 10, 12 or 15% SDS-PAGE (depending of the targeted protein size) and 228 
subsequently transferred to a nitrocellulose membrane. The membranes were blocked for 15-30 229 
min at room temperature (RT) in a blocking buffer (phosphate buffered saline (PBS), 0.1% 230 
Tween 20, 5% bovine serum albumin). Incubation with primary antibodies was performed 231 
overnight, at 40C and incubation with secondary antibodies was performed at RT for 1h. Proteins 232 
were revealed with chemiluminescence reagents (ProtoGlow ECL, National Diagnostics, USA). 233 
Images were quantified using ImageJ software.  234 
FACS analysis of cell cycle 235 
Tissue digestion and isolation of cells from control and nicotine-exposed mouse lungs for FACS 236 
analysis was performed as described in Donati et al. (the full technical description is available in 237 
the adjacent manuscript). The cells were always used fresh and analyzed by FACS at separate 238 
times corresponding to harvest. We used CD31 to mark the endothelial cells and CD326 for the 239 
epithelial cells. As described in the adjacent manuscript (method section), with the lung digestion 240 
protocol we limited the contamination of bronchial cells, and further focused only on alveolar 241 
cells by using markers that stain alveolar cells. To distinguish between type I and II epithelial 242 
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cells, we used podoplanin (PDPN) and major histocompatibility complex class II (MHCII) as 243 
described in Donati et al. (see antibodies section in supplementary information). All the analysis 244 
was performed in CD45 negative (CD45neg) population, to exclude blood-derived cells. The cell 245 
cycle analysis technique was adapted from Darzynkiewicz et al. (7). Briefly, 4x106 labelled cells 246 
were washed with PBS and fixed in PBS-0.5% formaldehyde for 15min. the fixative solution 247 
was removed by centrifugation, and the cell pellet was resuspended for 30min on ice in 1ml PBS, 248 
1% BSA, and 0.1% saponin containing 2ug/ml of Hoechst33342. After washing, cells were kept 249 
on ice until flow cytometer processing in 0.5ml PBS, 1% BSA containing 2ug/ml Hoechst33342. 250 
Analysis events were recorded on a BD LSR Fortessa and data were analyzed with FlowJo 251 
software (Version 10.5.0). 252 
Statistical analysis 253 
Results were expressed as mean ± standard deviation (sd), except for supplementary Figure 1 254 
(mean ± s.e.m.), and were analyzed in PRISM by either a) 2-way ANOVA multiple t-test 255 
analysis with recommended tukey or sidak correction for determining significance between 256 
control and nicotine-treated samples at different days or b) nested 1-way ANOVA with tukey 257 
correction for determining significance within the control samples at different days. The 258 
threshold for the significance was set at p≤0.05. Any analysis that differs from these described 259 
above is noted in the individual figure legend.  260 
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In utero exposure to nicotine leads to increased lung size at pnd16 262 
To address whether nicotine exposure in utero can affect lung morphology, we performed 263 
stereological analysis of lungs collected at three different postnatal days, namely pnd2, pnd8 and 264 
pnd16. All the analyses were performed on RML. We first examined the lung volume, 265 
parenchyma and septal volume, as well as septal surface area in control mice. All examined 266 
parameters increased significantly during normal alveolar development (Table 1). Mean linear 267 
intercept (MLI), describing the mean free distance in the air spaces, decreased as expected during 268 
alveolar development and significantly between pnd8 and 16 (Table 1). We then analyzed 269 
nicotine effect on these parameters. Nicotine increased lung and parenchyma volumes as well as 270 
septal surface area, slightly but significantly, at pnd16, but not at pnd2 and 8 (Fig. 1A, B, C and 271 
E). Septa volume and MLI values were not affected by nicotine (Fig. 1A, D and F).  272 
 273 
Nicotine affects gene profile at pnd2 but not pnd16  274 
In utero exposure to nicotine has been reported to affect gene expression in the brain (24, 56). 275 
We examined the whole lungs by RNAseq analysis at the end of saccular phase (pnd2) and then 276 
in the middle of alveolar phase (pnd16). Principal component analysis showed a nice segregation 277 
between nicotine and the control samples at pnd2, but not anymore at pnd16 (Fig. 2A). At pnd2, 278 
we obtained 3957 genes whose mRNA expression was significantly modified by nicotine. 279 
Amongst them, 2098 were upregulated and 1859 downregulated in the nicotine group compared 280 
to the control. The top 10 most upregulated and downregulated genes upon nicotine exposure are 281 
presented in Table 2. The majority of upregulated genes are bone-secreted proteins that do not 282 
normally have a lung function and are involved in bone and muscle energy metabolism. 283 
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However, some of the genes have been reported to promote lung cancer, such as distal-less 284 
homebox 5 (Dlx5), or act as tumor suppressors such as cyclin D binding myb-like protein 285 
(Dmp1) (20, 27). Among the downregulated top 10 genes, the majority are immune system 286 
related and some of them are associated with lung-related diseases such as asthma (Orosomucoid 287 
family, several single nucleotide polymorphisms in ORMDL3 were enriched in asthmatic 288 
population)(32), emphysema (Fgf23, increased in emphysema and COPD)(23) and COPD (Csf3, 289 
1719T single nucleotide polymorphism associated with protection against low lung function in 290 
COPD patients)(16). Furthermore, 31% of top 100 downregulated proteins are relevant for lung 291 
injury repair (for example, Il22, Il17f, Irg1, Il1b) (25, 45, 61). Amongst other nicotine 292 
downregulated genes is Serpin Peptidase Inhibitor Clade A (Serpina) genes whose deficiency has 293 
been associated to severe emphysema (31). 294 
Pathway analysis for data from pnd2 was performed with MetaCore using threshold 1.5 and 295 
significance ≤ 0.05. Results for the top 10 upregulated and downregulated pathways is shown in 296 
Fig. 2B and C. Top 10 pathways upregulated by nicotine can be sorted into several categories: 297 
cell cycle, epithelial to mesenchymal transition, stem cell related pathway, WNT signaling 298 
pathway, stromal-epithelial interaction, cell adhesion and DNA damage (Fig. 2B). On the other 299 
hand, the top 10 of nicotine downregulated pathways are associated with general immune 300 
response or asthma associated immune response (Fig. 2C).  301 
 302 
Kinetics of lung cell proliferation and apoptosis during development are not modified by 303 
nicotine  304 
First, we addressed the expression of Ki67, normally found only in proliferating cells (Fig. 3A), 305 
throughout lung development. We detected a proliferation peak at pnd8. On the other hand, 306 
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apoptosis analyzed by TUNEL staining showed no significant difference between analyzed days 307 
(Fig. 3B). Neither cell proliferation nor apoptosis was modified by nicotine. Similar results were 308 
obtained for the other two proliferation markers: cyclins, in particular cyclin A and D, and 309 
proliferating cell nuclear antigen (PCNA) (Fig. S1A-F). As we previously showed that nicotine 310 
affects the intrinsic apoptotic pathway in mouse epithelial cells (63), we addressed the expression 311 
of BCL and BAX molecules, key players in this pathway, at pnd2, 8 and 16 but again confirmed 312 
an absence of effect with nicotine (Fig. S2A and B). To understand the increase in lung volume 313 
observed with nicotine at pnd16, we further investigated RNAseq results that were linked to cell 314 
proliferation/apoptosis. We focused on cell cycle related genes and genes involved in the WNT 315 
pathway upregulated at pnd2 and reported to be crucial in the development of distal lung 316 
involved in gas exchange (13, 33). We found a stable expression of β-catenin, the central 317 
component of canonical WNT signaling pathway, throughout the three analyzed post-natal days, 318 
but detected an upregulation of survivin at pnd8, a downstream target of the β-catenin pathway 319 
involved in cell cycle and apoptosis regulation (Fig. 3C and D). The expression of both proteins 320 
was affected by nicotine, showing a significant increase at pnd2. This effect was again transient 321 
and no longer detected at pnd16 (Fig. 3C and D). The survivin peak detected at pnd8 in the 322 
control was not present at any of the analyzed days in nicotine samples, suggesting that survivin 323 
expression could follow different kinetics or that the peak, observed at pnd8 in the control, 324 
occurred earlier (Fig. 3D). 325 
 326 
Nicotine affects proliferation rates of AEC type I and endothelial cells at pnd8 and 16 327 
As some of the effect caused by nicotine might be cell specific and thereby lost in the whole lung 328 
population, we analyzed the cell cycle of individual lung cell types by FACS (see explanation of 329 
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the analysis in Fig. S3). Characterization of lung alveolar populations is described in detailed in 330 
Donati and colleagues (see adjacent manuscript). The major proliferating populations were 331 
vascular endothelial cells (CD31pos), mature AEC type II (MHCIIpos) and CD31negCD326neg 332 
population containing mesenchymal cells, with the highest values of 10.8, 5.4 and 4.8%, 333 
respectively, detected at pnd8 (Fig. 4A, B and D), which follow the same trend as the total lung 334 
cell populations analyzed by Ki67 (see Fig. 3A). The population of AEC type I 335 
(CD326posPDPNhigh) showed low proliferation rates of 0.6% and 0.7% at pnd2 and 8, 336 
respectively, which increased to 1.9% at pnd16 (Fig.4C). Nicotine significantly increased the 337 
proliferation rate of AEC type I at pnd8 from 0.7 to 1.6% and also decreased significantly the 338 
proliferation rate in endothelial cells at pnd8 and 16 from 10.8 to 9% and 3.65 to 1.4%, 339 
respectively (Fig. 4A and C). The proliferative value of AEC type II and CD31negCD326neg 340 
population was not affected by nicotine (Fig. 4B and D).  341 
 342 
Nicotine accelerates early alveolar maturation of AEC type I and II cells 343 
We wished to verify our results on nicotine affected cycling of endothelial and AEC type I cells 344 
and analyzed the remaining alveolar population. We therefore stained by IHC mouse lungs at 345 
pnd2, 8 and 16 with established alveolar cell type markers, namely PDPN for AEC type I (37), 346 
SPC for AEC type II (19) and CD31 for endothelial cells of lung capillaries and vessels (41). 347 
Because of their very thin and circle shaped cytoplasm, it is often hard to see the nucleus of 348 
endothelial cells of capillaries (Fig. 5B). Furthermore, it was also not easy to adequately match 349 
individual nuclei with membranous PDPN staining and therefore quantify the AEC type I cells 350 
by IHC (Fig. 5B). We were only able to quantify the SPC staining (Fig. 5A).  351 
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The density of AEC type II (SPCpos) remained stable throughout all the pnds between 4 and 352 
6x104/cm2. Nicotine had no effect on the amount of SPC stained cells at any of the days analyzed 353 
(Fig. 5A).  354 
Determination of percentages of endothelial and AEC type I cells was based on FACS method 355 
published by Donati and colleagues (see Materials & Methods section in adjacent manuscript). 356 
Furthermore, we used the same approach to address the percentages of other major alveolar cell 357 
types, such as Immune ad mesenchymal cells.  358 
We found that during development, nicotine caused a significant increase in the number of 359 
CD45pos cells, reflecting marginated immune cells (2), and therefore causing a relative decrease 360 
in CD45neg cells at pnd2 and 16 (Fig. 6A). The CD31negCD326neg population, that should contain 361 
the mesenchymal cells decreased towards pnd16 and was not affected by nicotine (Fig. 6B and 362 
Table 3). We further found a linear increase of vascular endothelial cells during alveolarization, 363 
from 7.7% at pnd2 to 15.5% at pnd16 (Fig. 6C and Table 3). At pnd2 nicotine caused an increase 364 
in the percentage of endothelial cells compared to control (Fig. 6C). As suggested by Donati and 365 
colleagues (see adjacent manuscript), the smaller percentage of AEC type I isolated at pnd8 and 366 
pnd16 compared to pnd2 probably reflects lung maturity. Indeed, in a more mature lung AEC 367 
type I form cell junctions with the extracellular matrix (ECM) and neighboring cells and 368 
isolation of these cells becomes more difficult by FACS. In fact, the highest yield of 8.1% for 369 
AEC type I at pnd2 had drastically dropped by pnd16 (Fig. 6D and Table 3). Nicotine induced a 370 
significant decrease of the number of extractable AEC type I to 6.2% at pnd2 and 1% at pnd8, 371 
suggesting that nicotine accelerates lung maturation (Fig. 6D).  372 
As expected the mature type II population, detected by the presence of MCHII, increased 373 
significantly during alveolarization from 0.4% at pnd2 to 34.8% at pnd16 (Fig. 6E and Table 3). 374 
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Here again, we found a significantly higher percentage of mature AEC type II in nicotine-treated 375 
lungs at pnd8 (from 18.55 to 25%, Fig. 6E), a finding that goes along with nicotine-induced 376 
increase in lung developmental kinetics. 377 
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DISCUSSION 378 
Nicotine is one of the main components of CS that affects early lung development (44). 379 
Animal studies associated nicotine exposure to decreased airways diameter, enlarged airspace or 380 
faster lung development, depending on the time frame and concentration of exposure, and also to 381 
the species exposed (51, 60). However, studies looking at alveolarization are rare and 382 
controversial (28, 54, 62). 383 
The purpose of this study was a) to analyze the normal alveolar lung development and b) 384 
to assess the effect of nicotine exposure during gestation and lactation on the alveolar phase of 385 
lung development.  386 
In control mice we observed a cell proliferation peak at pnd8 during lung alveolarization, 387 
confirmed by the analysis of three different proliferation markers: Ki67, PCNA, and cyclins 388 
(cyclin A and D). Furthermore, levels of survivin, a downstream molecule in the WNT pathway 389 
and involved in proliferation, also peaked at pnd8 (57). Levels of apoptosis were constant and 390 
low at all analyzed days. The three most abundant proliferating populations, vascular endothelial 391 
cells, mature AEC type II and CD31negCD326neg containing mesenchymal cells, determined by 392 
FACS, also showed a cell cycle peak at pnd8. AEC type I showed the lowest level of 393 
proliferation, reaching 1.9% at pnd16. These data are in agreement with those published by Yang 394 
and colleagues suggesting that AEC type I retain some degree of proliferative potential (62). 395 
Because detection of AEC type I by IHC is not accurate, as due to their elongated shape is 396 
sometimes hard to match the stained cell with its nuclei, our FACS results are all the more 397 
interesting as they enabled specific identification of AEC type I (see adjacent manuscript). 398 
Concurrently with lung maturation and extension of the capillary bed during the alveolar phase, 399 
vascular endothelial cells and mature AEC type II increased in percentage from pnd2 to pnd16. 400 
Downloaded from www.physiology.org/journal/ajplung at Univ Bern Hosp (130.092.012.073) on January 27, 2020.
Blaskovic, Page 21 
 
The percentages of AEC type II were between 5 and 7x104/cm2 of the lung (Fig. 5A), which is 401 
significantly lower than reported for adult rat and human lung (12-16%) (38). As it has been 402 
suggested that the alveolar phase lasts until young adulthood, it is probable that the percentage of 403 
AEC type II reported at pnd16 was not final and might increase further (54). Finally, we were 404 
not able to determine the total amount/percentage of AEC type I due to the limitation of available 405 
techniques. The percentage of AEC type I isolated at pnd2 (8.1%) and the corresponding low 406 
levels of cell cycling at all measured days suggest that the percentage detected at pnd2 is stable 407 
throughout alveolarization. The reported percentages of AEC type I in adult rat or human lung 408 
are 8.1% and 8.3% respectively, and are within the range of data described in this manuscript 409 
(38). Finally, stereological analysis, reported for RML, nicely reflected lung maturation during 410 
alveolar development and showed an increase of both, lung and parenchyma volume, as well as 411 
septal surface area from pnd2 to pnd16. On the other hand, mean linear intercept decreased 412 
during alveolarization, as expected, due to the process of lung septation. Values for lung RML 413 
volume range from 10 µl at pnd2 to 20 and 40 µl at pnd8 and 16, respectively. This is in line 414 
with values reported by Yang and colleagues, ranging from 90 to 100 µl for the entire left lung at 415 
pnd14 (62). Furthermore, the values obtained for MLI in our study are similar to those published 416 
by Pozarska and colleagues (40). 417 
We then assessed the effects of nicotine exposure on offspring’s lung development. 418 
Nicotine is very unstable and is indirectly measured by levels of cotinine, the main metabolic 419 
product of nicotine. There is no clear consensus on the levels of cotinine reported for passive 420 
smokers; the values vary from study to study and tissue analyzed (saliva, blood or urine). The 421 
values range between 5 (measured in saliva) and 30 ng/ml (measured in urine) (12, 14). In our 422 
study, the values for cotinine were 130 ± 88 ng/ml, measured in gestant mice and 70.6 ± 31 423 
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ng/ml measured in the pups after birth. Based on significantly higher level of cotinine detected in 424 
gestant mice, one might expect the highest effect of nicotine at pnd2. However, this trend was 425 
confirmed only for the results of RNAseq analysis, where we observed extensive genetic changes 426 
induced by nicotine at pnd2 affecting the cell cycle, the canonical WNT pathway, cell adhesion 427 
and immune system and for the percentage of endothelial cells. Other parameters, such as 428 
percentages of other lung populations and the analysis of their cell cycle obtained by FACS were 429 
also affected at later analyzed days. Nevertheless in almost all analyses, the effect of nicotine 430 
was no longer present by pnd16, except for the “bigger lung” that was no longer observed in 431 
adult mice (Fig. S4). Taken together, these data suggest, that while nicotine induces a variety of 432 
changes, these changes are not permanent. Such a transient effect was reported previously, in 433 
rats, in the study by Petre et al, where nicotine induced initial decrease in the airspace size 434 
immediately after the rats are born, that was followed by a catch-up increase detected in 3 weeks 435 
old rats and complete loss of the effect by week 12 after birth (39). 436 
Several results from our FACS analysis hint towards nicotine-induced shift in phase and 437 
acceleration of lung maturation, a hypothesis already brought forward by Sandberg and 438 
colleagues in 2004 (51), although metabolic pathways have not been addressed in our study. 439 
First, we detected a nicotine-induced increase in percentages of vascular endothelial cells at pnd2 440 
and mature AEC type II at pnd8 (Fig. 6C and E). In both cases, the control lung eventually 441 
reached the same values by pnd8 and 16 respectively. Second, in spite of nicotine-induced 442 
increase in cell cycle detected for AEC type I cells at pnd8, we could isolate lower amount of 443 
this cell type at both pnd2 and 8. As explained in Donati et al (see adjacent manuscript), the 444 
isolation of AEC type I cells becomes more difficult with aging because a) they undergo 445 
extensive structural changes during development, including cell flattening, elongation and 446 
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folding (62) and b) they develop an increasing number of cell-cell and cell-ECM interactions. 447 
We have confirmed this phenomenon in control mice, where after pnd4-5 the percentage of AEC 448 
type I isolation drastically drops (data not shown). Therefore, we believe that the lower isolation 449 
efficiency of AEC type I at pnd2 and 8 from nicotine-exposed lungs reflects the increased 450 
maturation of this lung structure. Third, nicotine-induced increase in lung volume, observed at 451 
pnd16, did not persist in adult age. Such transient effect of nicotine on lung volume is consistent 452 
with the shift in phase hypothesis. Forth, results from RNAseq analysis at pnd2 showed nicotine-453 
induced upregulation of genes involved in alveolarization, such as genes related to elastin 454 
deposition (insulin like growth factor 1 (Igf1) and its receptor, Ltbp4, fibrilin) and septa 455 
formation (Hox, Pdgf-a, Nrp1) (3, 11, 15, 22, 30). Finally, two genes involved in different stages 456 
of lung development were upregulated in our transcriptomic analysis from nicotine samples at 457 
pnd2. IGF1 receptor, whose absence is associated with delayed saccular development (11) and 458 
WNT5a related to alveolar development in mice. All these results could support the hypothesis 459 
of nicotine-induced lung maturation. Furthermore, ECM proteins such as collagens, known to be 460 
involved in cell shape regulation, were also upregulated in nicotine samples. Despite the fact that 461 
gene up- or downregulation disappeared at pnd16, changes in lung cell dynamics is of 462 
importance in the context of in utero and early life programing, leading to increased 463 
susceptibility of adults to lung and non-lung diseases, a concept suggested as “fetal origin 464 
hypothesis” by Barker and Osmond (1). In line with this, WNT signaling pathway, already 465 
shown to be affected by nicotine in various lung cell lines (50, 64, 65) as well as in vivo in mice 466 
(6) was also reported to be involved in maintaining AEC type II stemness. In particular, Nabhan 467 
and colleagues, found that high levels of WNT pathway maintained the progenitors pool while 468 
the decrease in WNT lead to transdifferentiation of this pool into a mature AEC type I (35). 469 
Downloaded from www.physiology.org/journal/ajplung at Univ Bern Hosp (130.092.012.073) on January 27, 2020.
Blaskovic, Page 24 
 
Therefore, nicotine effect on alveolar stem cell niche via WNT as well as nicotine-induced 470 
transcriptomic changes in genes such as Serpina involved in emphysema and genes related to 471 
lung injury might contribute to a higher susceptibility to diseases in adulthood. This hypothesis 472 
remains an open question and requires further research. Finally, understanding the impact of 473 
nicotine vs CS is required in the context of the increasing interest in CS replacement therapies.474 
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CONCLUSIONS 475 
Our study describes the dynamics of cell cycle and lung alveoli composition during the 476 
developmental alveolar phase and identifies three main types of cells responsible for the 477 
proliferation peak observed at pnd8, namely vascular endothelial cells, mature AEC type II, and 478 
CD31negCD326neg population containing, amongst others, mesenchymal cells. We found that 479 
nicotine induces a variety of strong effects immediately after birth that transiently increase the 480 
kinetics of lung development, and are then lost by pnd16. Finally, we also found that nicotine 481 
decreases the level of cell cycle of vascular endothelial cells at pnd8 and 16, thereby affecting 482 
one of the cell types involved in gas exchange. Even so the morphological changes do not seem 483 
to persist beyond pnd16, prenatal exposure to nicotine as well as to other compounds such as 484 
alcohol, stress, famine or toxicants contained in CS might result in a poor health outcome in 485 
adulthood. Indeed, epigenetic changes in different genes have been reported for nicotine. It will 486 
be important to understand whether this effect persists during the whole alveolar development 487 
phase and also later in life, and to address whether these subtle and transient changes detected at 488 
the beginning of alveolarization can leave a more permanent mark and affect lung health later in 489 
life. 490 
  491 
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FIGURE LEGENDS 694 
Figure 1. Morphology and stereological analysis of pup lungs. Stereological analysis 695 
was performed on H&E lung sections of post-natal day (pnd) 2, 8 and 16 from control 696 
and nicotine group (A). lung volume (B), parenchyma volume (C), septal volume (D), 697 
septal surface area (E) and mean linear intercept (MLI, F) were measured at pnd2, 8 698 
and 16. Control/Nicotine group; For pnd2 and 16 n=5 animals was used for each 699 
group (for pnd2, 2 females (F), 2 males (M) and one not determined in the control 700 
group and 3M and 2F in the nicotine group; for pnd16, 5M in the control group and 701 
3F and 2M in the nicotine group), for pnd8 n=3 animals for each group (2F and 1M in 702 
the control group and 1F and 2M in the nicotine group). Results are presented as 703 
individual plots and mean values ±SD. * p<0.05; n.s. not significant. The comparison 704 
was done between control and nicotine group for each time point with two way 705 
ANOVA and Bonferroni correction. 706 
 707 
Figure 2. Comparison of RNAseq analysis of lung extracts of control and nicotine 708 
exposed mice. Analysis of RNAseq data, was done at pnd2 (n=6 animals for control 709 
group (4F and 2M) and n=5 animals for nicotine group (3F and 2M)) and pnd16 (n=5 710 
animals for control group (2F and 3M) and n=3 animals for nicotine group(2F and 711 
1M)) and is represented as a two-dimensional MDS plot with samples in red for the 712 
control group and in purple for the nicotine group (A). Pathway analysis performed at 713 
pnd2 with MetaCore software (with threshold of two and significance p<0.05) is 714 
shown in (B) for nicotine-induced pathways and in (C) for nicotine-downregulated 715 
pathways. 716 
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Figure 3. Nicotine upregulates canonical WNT/β-catenin signaling pathway. Lung 717 
tissues were processed at pnd2, 8 and 16 from control and nicotine group and 718 
analyzed by immunohistochemistry (A and B) and western blot (C and D). To address 719 
cell proliferation we measured Ki67 expression (A, n=4-11 animals/pnd/condition) 720 
and for apoptosis we used TUNEL staining (B, n=4-8 animals/pnd/condition). WNT 721 
pathway was accessed by measuring the expression of β-catenin (C, n=3 722 
animals/pnd/condition) and survivin (D, n=3 animals/pnd/condition). Actin was used 723 
as a loading control in western blot analysis (C and D).* significance for nicotine 724 
treatment vs. control between different pnds. #significance pnd16/8 vs pnd2; † 725 
significance pnd16 vs pnd8; ####/†††† p<0.0001; n.s, not significant (A and B). The 726 
average of sepaate western blot experiments is shown. p<0.05; n.s, not significant. T-727 
test analysis was performed between control and nicotine group for each time point (C 728 
and D). 729 
 730 
Figure 4. Nicotine affects cell cycling of vascular endothelial cells and AEC type I. 731 
Cells were isolated from mouse lung at pnd2, 8 and 16 and percent of cycling cells 732 
was determined by Hoechst staining via FACS in different cell populations: vascular 733 
endothelial cells (CD31pos) (A), mature AEC type II cells (CD326posMHCIIpos) (B), 734 
AEC type I cells (CD326posPDPNhigh) (C) and mesenchymal cells (CD31negCD326neg ) 735 
(D). n = 5-10 animals/condition and pnd were used for the analysis. Graphical 736 
representation of the data are shown; * significance for nicotine treatment vs. control 737 
between different pnds. #significance pnd16/8 vs pnd2; † significance pnd16 vs pnd8; 738 
*/# p<0.05; ##/†† p<0.01; ####/†††† p<0.0001; n.s. not significant. 739 
 740 
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Figure 5. IHC of alveolar cells in nicotine–exposed and non-exposed pups. Lung 741 
paraffin sections of the control and nicotine–exposed pups from pnd2, 8 and 16 were 742 
stained with IgG antibody control (upper panel) and AEC type II marker (SPC) 743 
(middle and lower panel)(A). Graphical quantification for this marker is also shown in 744 
(A). SPC positive cells at pnd2 and 16 are indicated with red arrows. Analysis was 745 
performed on 10 different fields/lung (dimensions 210µm x 110µm) and 3-5 746 
animals/group. Results are presented as total number of positive cells per cm2 of lung 747 
tissue. * significance for nicotine treatment vs. control between different pnds. 748 
#significance pnd16/8 vs pnd2; † significance pnd16 vs pnd8; */# p<0.05; ##/†† p<0.01; 749 
### p<0.001; n.s. not significant. Lung cryosections of the control pups from pnd2 and 750 
16, stained for AEC type I marker PDPN and the marker of vascular endothelial cells, 751 
CD31, are shown in (B). The first column represents staining with IgG control, and 752 
the middle and last column show staining with the corresponding antibodies. 753 
 754 
Figure 6. FACS isolation of alveolar cells during lung development in nicotine-755 
exposed and non-exposed pups. Cells were isolated from mouse lung at pnd2, 8 and 756 
16 and sorted by FACS based on expression of CD45 marker. CD45neg population (A) 757 
was further analyzed for the expression of following markers: mesenchymal cells 758 
(CD31negCD326neg ) (B), CD31posPDPNneg (vascular endothelial cells) (C), 759 
CD326posPDPNhigh (AEC type I cells) (D) and CD326posMHCIIpos (mature AEC type 760 
II cells) (E). n = 5-10 animals/condition and pnd were used for the analysis. Graphical 761 
representation of the data are shown; * significance for nicotine treatment vs. control 762 
between different pnds. #significance pnd16/8 vs pnd2; † significance pnd16 vs pnd8; 763 
*/# p<0.05; ### p<0.001; ****/####/†††† p<0.0001; n.s. not significant. 764 
  765 
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SUPPLEMENTAL MATERIAL 766 
The supplemental material (Figures S1 to S4 and the list of antibodies and reagents) is 767 
deposited in a generalist public access repository figshare 768 
(https://figshare.com/s/56282a06102729a7ee90) (DOI:10.6084/m9.figshare.8201696).  769 
 770 
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Blaskovic et al. Figure 4.
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B. PDPN and CD31 staining
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TABLES 
Table 1. Lung morphometry of mouse lungs analyzed from pnd2 to pnd16 
 control 
 pnd2 pnd8 pnd16    
Morphometry (n=5) (n=3) (n=5) pa Pb Pc 
Lung volume (cm3) 0.01 ± 0.002 0.022 ± 0.004 0.04 ± 0.008 0.0513 <0.0001 0.0092 
Parenchyma volume (cm3) 0.009 ± 0.002 0.019 ± 0.004 0.03 ± 0.008 0.0638 <0.0001 0.0066 
Septa volume (cm3) 0.002 ± 0.001 0.005 ± 0.001 0.008 ± 0.002 0.0458 0.0005 0.1128 
Septal surface area (cm2) 5.3 ± 1.4 11.2 ± 2.1 28.15 ± 5.9 0.1566 <0.0001 0.0004 
Mean linear intercept (µm) 35.1 ± 2.4 34.4 ± 1.2 24.5 ± 2.2 0.8916 <0.0001 0.0002 
 
pnd = post-natal day;  
Mean values ± SD are reported. 
P Pairwise statistical comparison one-way ANOVA with tukey correction was performed between day 2 and 8 (Pa), day 2 and 16 (Pb), and day 8 
and 16 (Pc) 
Values reported are for lung right middle lobe. 
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Table 2. Top 10 of UP- and DOWN-regulated genes upon nicotine in utero exposure at pnd2 






Mepe Matrix Extracellular 
Phosphoglycoprotein 







Dlx5 Distal-Less Homeobox 5 Osteoblast differentiation Oncogene in lung cancer 175 
Dmp1 Cyclin D binding myb-like 
protein 1 
P53 pathway regulator Lung cancer 124 
Myoz3 Myozenin 3 Regulator of calcineurin N/A 119 
Atp1b4 ATPase Na+/K+ 
Transporting Family 
Member Beta 4 
Regulation of active 
transport 
N/A 81 




Myh2 Myosine heavy chain Muscle contraction pneumonia 64 
Ctrnd Cholinergic receptor 
Nicotinic Delta Subunit 
Acetylcholine/nicotine 
receptor
Lung cancer 63 
Fgf23 Fibroblast growth factor 23 Phosphate and vitamine D 
metabolism 
Fgf-23−/− mouse exhibit 
premature aging and lung 
emphysema 
-606.5 
Csf3 Granulocyte colony 
stimulating factor 3 
production, differentiation, 
and function of granulocytes
Lung metastasis ;  -219 
8030474K03Rik  N/A N/A -196 
Il22 Interleukin 22 Innate and adaptive immune 
response 
Lung epithelial repair after 
injury 
-178.5 
Cxcl2 C-X-C Motif Chemokine 
Ligand 2 
Angiogenic chemokine Regulation of airway smooth 
muscle cell migration 
-148.4 




immune lung injury after 
RSV infection by reducing 
ROS production 
-132 
Il17f Interleukin17f Innate and adaptive immune 
response 
Protection from bacteri/fungi 
and involved in repair 
-129 
Orm2 Orosomucoid 2 modulating immunity, 
maintaining the barrier 
function of capillary, 
sphingolipid metabolism
asthma -96 
Orm3 Orosomucoid 3 modulating immunity, 
maintaining the barrier 
function of capillary, 
sphingolipid metabolism 
asthma -92 
Orm1 Orosomucoid 1 modulating immunity, 
maintaining the barrier 
function of capillary, 
sphingolipid metabolism 
asthma -90 
FC  = fold change 
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Table 3. Relative abundance of alveolar cells analyzed by FACS during lung development from pnd2 to pnd16 
 control 
 pnd2 pnd8 pnd16     
Cell type % (n=5) (n=8) (n=6) pa Pb Pc F(DFn, Dfd) 
CD45neg 88.8 ± 0.8 84.9 ± 1.5 67 ± 4.5 0.1362 0.0004 0.0006 104(2,4) 
CD45negCD31negCD326neg 53.4 ± 4.5 54.25 ± 3.7 37.3 ± 6.6 0.9898 0.0300 0.0194 13.2(2,4) 
EC (CD31posPDPNneg) 7.7 ± 1.9 10.6 ± 1.5 15.5 ± 1.6 0.0788 0.0034 0.0125 31(2,4) 
AEC type I(CD326posPDPNhigh) 8.1 ± 1.1 3.2 ± 1.3 0.3 ± 0.2 0.0049 0.0011 0.0271 54.3(2,4) 
AEC type II(CD326posMHCIIpos) 0.4 ± 0.1 18.55 ± 7.9 34.8 ± 6.1 0.0659 0.0082 0.0584 18.4(2,4) 
Percentages of endothelial and epithelial populations are expressed as mean ± SD after exclusions of CD45pos population. 
Nested one-way ANOVA was performed to determine statistical significance.  
P Pairwise statistical comparison one-way ANOVA with Turkey correction was performed between day 2 and 8 (Pa), day 2 and 16 (Pb), and day 
8 and 16 (Pc); degrees of freedom are reported with degrees of freedom numerator (DFn) and denominator (DFd) values. 
pnd = post-natal day; EC = endothelial cells; PDPN = podoplanin; MHCII = major histocompatibility complex class II 
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